Stability trials, in progress.

Independent stability and degradation studies we commission from ILS Laboratories, listed here the day they are requested. Each study's report is published in the COA portal when the laboratory delivers it. Nothing is summarized before then.

2 studies★ Pending

★ PendingTrial 01 Disguised Alpha GLP-3 RT vials in 10, 20, 30 and 60 mg, side by side

Stability study · fill sizes · ILS Laboratories

GLP-3 RT: 10, 20, 30 and 60 mg vials

Do the larger fills degrade differently over time? Four vial sizes compared before and after reconstitution, with fill size separated from concentration.

10 mg20 mg30 mg60 mgBefore + after reconstitution

Requested
★Design & quoteQuotePending
At the labAt lab
Testing
Published

Study design

What we are evaluating

Remaining GLP-3 RT content, purity and degradation products relative to initial testing.
Stability before and after reconstitution, run as separate study arms.
The effects of storage temperature, light exposure and repeated handling.
Whether differences are associated with total vial content or the final reconstituted concentration.

Design brief to the lab

Separate fill-size effects from concentration effects, with suitable controls and sampling intervals across all four sizes.

Pending: design and quote requested from ILS Laboratories. Results are published in the COA portal when the laboratory reports.

★ PendingTrial 02 Disguised Alpha NAD+ 200 mg/mL in an amber 20 mL vial beside a clear 20 mL vial

Stability study · clear vs amber · ILS Laboratories

NAD+: clear vials against amber vials

Does amber glass preserve NAD+ better than clear glass? Same formulation, concentration, fill volume and closure in both arms, so vial color is the only variable.

Clear glassAmber glassRefrigeratedRoom temperature

Requested
★Design & quoteQuotePending
At the labAt lab
Testing
Published

Study design

What we are evaluating

Remaining NAD+ content and degradation products over time.
Changes in appearance, color, clarity and pH where applicable.
Clear versus amber vials under controlled light exposure, with light-protected controls.
Refrigerated storage against room-temperature exposure.

Design brief to the lab

One formulation, one concentration, one fill volume and one closure system. Vial color is the primary variable; light-protected controls sit alongside both arms.

Pending: design and quote requested from ILS Laboratories. Results are published in the COA portal when the laboratory reports.

How trials are reported

Pending means pending.

A trial appears on this page the day it is requested. Its status moves from Pending to In progress to Reported, and the final report is published as a certificate next to the batch certificates it belongs with. We do not summarize a result before the laboratory does.

Browse the COA portal

For research use only · disguisedalpha.com

Independent laboratoryILS Laboratories designs and runs each study. The lab is ISO/IEC 17025 accredited and already tests every batch we sell.

Status you can checkPending, In progress, Reported. The status on each card is updated here as the study moves.

Published as certificatesFinal reports land in the COA portal, the same place you read the batch certificates, so the trial and the lots it covers sit together.